Breaking News Instant updates and real-time market news.

DGX

Quest Diagnostics

$110.72

0.21 (0.19%)

, AMZN

Amazon.com

$1,739.08

27.79 (1.62%)

09:35
07/10/18
07/10
09:35
07/10/18
09:35

Quest Diagnostics upgraded to Outperform at Evercore ISI on improved volume view

As reported earlier, Evercore ISI analyst Ross Muken upgraded Quest Diagnostics (DGX) to Outperform from In Line and raised his price target to $121 from $108. The analyst notes that the company will likely be the beneficiary of improved volumes, stable pricing, heightened M&A and fund flows amid the heightened volatility within the Rx supply chain. Muken believes that the company is "less exposed to political risk and big bad Amazon (AMZN)" competition, while its new management has also effectively reduced costs and deployed capital.

DGX

Quest Diagnostics

$110.72

0.21 (0.19%)

AMZN

Amazon.com

$1,739.08

27.79 (1.62%)

  • 10

    Jul

  • 18

    Jul

  • 16

    Aug

DGX Quest Diagnostics
$110.72

0.21 (0.19%)

06/25/18
06/25/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. BorgWarner (BWA) upgraded to Buy from Neutral at Goldman Sachs with analyst David Tamberrino saying he believes the company will outperform supplier peers late in the North American auto cycle. 2. Norfolk Southern (NSC) upgraded to Buy from Neutral at Citi with analyst Christian Wetherbee stating that he sees solid upside to consensus estimates and the potential for multiple appreciation based on "sustainably better" free cash flow. 3. Quest Diagnostics (DGX) upgraded to Overweight from Equal Weight at Barclays with analyst Jack Meehan citing the company's "very favorable" risk-reward profile and current levels. 4. Ciena (CIEN) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Meta Marshall saying recent meetings with management give her confidence that revenue momentum can persist at least for the next year. 5. Microsoft (MSFT) upgraded to Overweight from Neutral at Atlantic Equities with analyst James Cordwell stating the company has successfully managed the cloud transition, while expanding its addressable market, and should now be a primary beneficiary of enterprises undertaking digital transformations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/27/18
DBAB
06/27/18
DOWNGRADE
DBAB
Hold
Quest Diagnostics downgraded to Hold from Buy at Deutsche Bank
06/27/18
06/27/18
DOWNGRADE

Hold
Deutsche Bank downgrades Quest, LabCorp to Hold with catalysts 'exhausted'
As previously reported, Deutsche Bank analyst Dan Leonard downgraded Quest Diagnostics (DGX) and LabCorp (LH), both to Hold from Buy, stating that he previously believed that hospital labs, which could be more impaired by Medicare reimbursement cuts, would be willing sellers, but the slower than expected pace of deals has made him question this assumption. He continues to see durable organic growth for Quest's and LabCorp's diagnostics businesses, but he now wonders if some headwinds had abated in the way he'd previously assumed, Leonard added.
07/10/18
EVER
07/10/18
UPGRADE
EVER
Outperform
Quest Diagnostics upgraded to Outperform from In Line at Evercore ISI
AMZN Amazon.com
$1,739.08

27.79 (1.62%)

07/02/18
LEHM
07/02/18
NO CHANGE
LEHM
Equal Weight
Express Scripts most exposed to mail order market disruption, says Barclays
Barclays analyst Steve Valiquette believes Express Scripts (ESRX) is most exposed to Amazon's (AMZN) acquisition of PillPack. The analyst estimates Express Scripts has 35%-40% share of the U.S. prescription mail order market. The mail order prescription market is the most immediate area for possible disruption from Amazon/PillPack given the nature of PillPack's business and Amazon's existing mail-order logistical infrastructure, Valiquette tells investors in a research note. The analyst assumes PillPack captures 1% share of the U.S. mail-order Rx market in 2019, and improves its market share further by 1% each year afterwards. Valiquette calculates a "hypothetical" 13c negative earnings per share impact for Express Scripts in 2019. He believes the negative earnings impact could reach 45c by 2021, but thinks Express Scripts could undertake expense cuts to offset some of this. For Walgreens Boots Alliance (WBA), the analyst calculates a negative earnings per share impact of 15c in 2020, or 2% of his current estimate assuming no additional cost-cutting. Valiquette has Equal Weight ratings on both Express Scripts and Walgreens.
07/02/18
JEFF
07/02/18
NO CHANGE
JEFF
Jefferies sees rotation coming to Technology, downgrades sector rating
Jefferies equity strategist Steven DeSanctis downgraded his rating on the Technology sector to a Market Weight from Overweight. "Sentiment is too strong and we sense a rotation coming," DeSanctis tells investors in a research note. On Biotech, the analyst recommends staying selective as the sector "is nearing an all-time high weight in small growth benchmarks." On Financials, DeSanctis says that while the sector has not worked for 18 months, rising interest rates, more deal activity and cheaper valuations could get the group moving higher.
07/09/18
SBSH
07/09/18
UPGRADE
Target $81
SBSH
Buy
CVS Health assumed to Buy from Neutral at Citi
Citi analyst Ralph Giacobbe upgraded CVS Health (CVS) to Buy after assuming coverage of the name. The analyst raised his price target for the shares to $81 from $68. While the execution of an integrated healthcare superstore post the pending Aetna (AET) acquisition may be a long way off, the concept will resonate with employers and individuals, Giacobbe tells investors in a research note. He believes deal integration and competitive Amazon (AMZN) risk are "somewhat overstated particularly in the context of heavily discounted valuation."
07/09/18
SBSH
07/09/18
DOWNGRADE
Target $69
SBSH
Neutral
Walgreens Boots Alliance downgraded to Neutral from Buy at Citi
Citi analyst Ralph Giacobbe downgraded Walgreens Boots Alliance (WBA) to Neutral after assuming coverage of the name. The analyst lowered his price target for the shares to $69 from $76. The analyst finds it difficult to argue for "meaningful multiple expansion" given headwinds from industry pressures and a dynamic and changing backdrop. Further, Amazon's (AMZN) recent acquisition of PillPack reignites "further competitive fears," Giacobbe tells investors in a research note.

TODAY'S FREE FLY STORIES

GLD

SPDR Gold Trust

$115.24

-0.48 (-0.41%)

09:35
10/15/18
10/15
09:35
10/15/18
09:35
Technical Analysis
Technical Take: SPDR Gold Trust breaks downtrend, breaks range highs »

The SPDR Gold Trust (GLD)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:35
10/15/18
10/15
09:35
10/15/18
09:35
General news
Treasury Option Action: put positioning on bonds »

Treasury Option Action:…

SRTS

Sensus Healthcare

$7.14

0.07 (0.99%)

09:33
10/15/18
10/15
09:33
10/15/18
09:33
Downgrade
Sensus Healthcare rating change  »

Sensus Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

BAC

Bank of America

$28.42

0.07 (0.25%)

09:33
10/15/18
10/15
09:33
10/15/18
09:33
Hot Stocks
Breaking Hot Stocks news story on Bank of America »

Bank of America says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 24

    Oct

CAKE

Cheesecake Factory

$50.23

-0.64 (-1.26%)

09:32
10/15/18
10/15
09:32
10/15/18
09:32
Downgrade
Cheesecake Factory rating change  »

Cheesecake Factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 05

    Nov

  • 14

    Nov

EDU

New Oriental Education

$61.54

2.94 (5.02%)

09:31
10/15/18
10/15
09:31
10/15/18
09:31
Upgrade
New Oriental Education rating change  »

New Oriental Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

EQBK

Equity Bancshares

$36.40

-0.82 (-2.20%)

09:30
10/15/18
10/15
09:30
10/15/18
09:30
Upgrade
Equity Bancshares rating change  »

Equity Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

BAC

Bank of America

$28.42

0.07 (0.25%)

09:30
10/15/18
10/15
09:30
10/15/18
09:30
Hot Stocks
Bank of America says it will benefit from September rate hike. »

Says transactions per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 24

    Oct

SCYX

Scynexis

$1.18

-0.01 (-0.84%)

09:29
10/15/18
10/15
09:29
10/15/18
09:29
Hot Stocks
Scynexis doses first patient in Phase 3 study of Ibrexafungerp »

Scynexis announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

WFC

Wells Fargo

$52.12

0.7 (1.36%)

09:28
10/15/18
10/15
09:28
10/15/18
09:28
Recommendations
Wells Fargo analyst commentary  »

Wells Fargo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 21

    Oct

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

EQBK

Equity Bancshares

$36.40

-0.82 (-2.20%)

09:28
10/15/18
10/15
09:28
10/15/18
09:28
Upgrade
Equity Bancshares rating change  »

Equity Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

GD

General Dynamics

$191.97

-0.97 (-0.50%)

09:28
10/15/18
10/15
09:28
10/15/18
09:28
Hot Stocks
Gulfstream Aerospace raises safety, efficiency for operators »

Gulfstream Aerospace…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

SRG

Seritage Growth Properties

$41.81

-0.85 (-1.99%)

, SHLD

Sears

$0.40

0.05 (14.28%)

09:24
10/15/18
10/15
09:24
10/15/18
09:24
Hot Stocks
Seritage says active projects will 'continue uninterrupted' after Sears filing »

Seritage Growth…

SRG

Seritage Growth Properties

$41.81

-0.85 (-1.99%)

SHLD

Sears

$0.40

0.05 (14.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEOH

Methanex

$75.11

1.35 (1.83%)

09:23
10/15/18
10/15
09:23
10/15/18
09:23
Recommendations
Methanex analyst commentary  »

Methanex price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$18.02

0.31 (1.75%)

09:19
10/15/18
10/15
09:19
10/15/18
09:19
Upgrade
Marvell rating change  »

Marvell upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

PZZA

Papa John's

$52.91

0.485 (0.93%)

09:18
10/15/18
10/15
09:18
10/15/18
09:18
Recommendations
Papa John's analyst commentary  »

Papa John's U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
10/15/18
10/15
09:18
10/15/18
09:18
Options
Overnight activity included 379 trades in SPX and 61 trades in VIX »

379 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIF

Tiffany

$112.93

1.81 (1.63%)

09:17
10/15/18
10/15
09:17
10/15/18
09:17
Recommendations
Tiffany analyst commentary  »

KeyBanc bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PERY

Perry Ellis

$27.44

0.01 (0.04%)

09:15
10/15/18
10/15
09:15
10/15/18
09:15
Hot Stocks
Perry Ellis announces license agreement with Racing Shield »

Perry Ellis announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 03

    Mar

ANET

Arista Networks

$222.32

6.7 (3.11%)

, CSCO

Cisco

$45.69

1.56 (3.54%)

09:12
10/15/18
10/15
09:12
10/15/18
09:12
Recommendations
Arista higher after William Blair uncovers 'game-changing' Pentagon win »

William Blair analyst…

ANET

Arista Networks

$222.32

6.7 (3.11%)

CSCO

Cisco

$45.69

1.56 (3.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 01

    Nov

ABCD

Cambium Learning

$12.05

0.27 (2.29%)

, TNDM

TNDM

09:12
10/15/18
10/15
09:12
10/15/18
09:12
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Cambium Learning…

ABCD

Cambium Learning

$12.05

0.27 (2.29%)

TNDM

TNDM

ACRX

AcelRx

$3.95

(0.00%)

HRS

Harris

$154.88

0.61 (0.40%)

LLL

L3 Technologies

$195.99

0.74 (0.38%)

PGNX

Progenics

$5.55

-0.035 (-0.63%)

BAC

Bank of America

$28.42

0.07 (0.25%)

AAXN

Axon

$58.91

2.7 (4.80%)

NTRI

Nutrisystem

$37.12

1.11 (3.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 24

    Oct

  • 29

    Oct

  • 03

    Nov

  • 27

    Nov

MCD

McDonald's

$163.82

0.87 (0.53%)

09:11
10/15/18
10/15
09:11
10/15/18
09:11
Upgrade
McDonald's rating change  »

McDonald's upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

YVR

Liquid Media

$4.35

1.55 (55.36%)

09:11
10/15/18
10/15
09:11
10/15/18
09:11
Hot Stocks
Liquid Media effects 1-for-5 reverse stock split »

Liquid Media announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:11
10/15/18
10/15
09:11
10/15/18
09:11
Conference/Events
Morgan Stanley to hold an analyst/industry conference call »

Vice President Kaufman…

DLTR

Dollar Tree

$81.15

1.62 (2.04%)

09:10
10/15/18
10/15
09:10
10/15/18
09:10
Downgrade
Dollar Tree rating change  »

Dollar Tree downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.